Propanc Biopharma, Inc.
NASDAQPPCB short interest
Full pulse commentary is for ORTEX subscribers. The live data picture for PPCB below stays open — short interest, options flow, signals, and historical context.
Sign up free to read pulse →Short interest % of float, cost to borrow, utilization, and put/call ratio for PPCB are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
Snapshot as of 15 May 2026
Propanc Biopharma heads into its May 18 earnings release as one of the more volatile micro-cap biotechs on the Nasdaq calendar, with short interest surging and its stock price hitting new lows. The short interest story…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PPCB — free to start on ORTEX.
Sign up for free →Open PPCB on ORTEX